Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Fortrea Holdings Inc (FTRE)

  • Business News
  • June 11, 2025, 19:53 UTC
  • 4

Fortrea Holdings Inc. (FTRE) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Market reaction Comment Full text

West Pharmaceutical Services Inc (WST)

  • Business News
  • June 11, 2025, 19:50 UTC
  • 6

West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Market reaction Comment Full text

Biofrontera Inc. (BFRI)

  • Business News
  • June 11, 2025, 19:00 UTC
  • 5

Biofrontera Notification (BFRI)

Market reaction Comment Full text

Biofrontera Inc. (BFRI)

  • Business News
  • June 11, 2025, 19:00 UTC
  • 4

BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • June 11, 2025, 18:56 UTC
  • 5

What Happened to the Nintendo Switch Version of Genshin Impact?

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • June 11, 2025, 18:52 UTC
  • 5

Genshin Impact Patch 5.7 “A Space and Time for You” – Coming June 18, 2025

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • June 11, 2025, 18:34 UTC
  • 5

Nintendo Switch 2 Smashes Records With 3.5 Million+ Units Sold in First 4 Days

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • June 11, 2025, 17:44 UTC
  • 7

Superman (2025): Final Trailer, Release Date Set, and Ticket Sales Begin

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • June 11, 2025, 17:32 UTC
  • 7

What Is Screen Tearing and How Do You Fix It?

Market reaction Comment Full text

Nuvation Bio Inc. (NUVB)

  • Business News
  • June 11, 2025, 17:20 UTC
  • 6

Nuvation Bio Inc. - U.S. Food and Drug Administration Approves Nuvation Bio’s IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer

Market reaction Comment Full text
  • Previous
  • 200
  • 201
  • 202
  • 203
  • 204
  • Next

Search

News categories

  • Technical Exchange News(9492)
  • Event(407)
  • SEC News(155849)
  • FDA Approval(8880)
  • Company Report(721)
  • Business News(105714)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin